Impact of Number of Rank of B-lactam Antibiotics on Emergence on Multidrug Resistant Bacteria
- Conditions
- Resistant InfectionAntibiotic Resistant InfectionBeta Lactam Resistant Bacterial InfectionBacterial Resistance
- Interventions
- Procedure: number of Beta lactam class prescription for the same infection
- Registration Number
- NCT03752476
- Lead Sponsor
- Centre Hospitalier Universitaire de Besancon
- Brief Summary
This study evaluates the impact of rank of Beta lactam antibiotics on emergence of mutlidrug resistant bacteria colonization in intensive care
It's retrospective case controle study. Cases are colonized patient by multidrug resistant bacteria hospitalized in intensive care during the fist hospitalization in intensive care. Temoin are patients with the same characteristics than case but no colonized by multidrug resistant bacteria.
- Detailed Description
The emergence of multidrug resistant is a wordwide problem. B lactam resistant increase. The antibiotic prescription impact this problem.
B lactam antibiotic is prescribed everyday in intensive care unit. The switch of antibiotic is common. Antibiotic classes inclue a lot of rank with different spectum that impact the occurrence of resistant.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 1300
- all patient hospitalized more than 48 hours in intensive care unit in Besançon between january 2016 and december 2017
- patient under guardianship
- patient allergic to Beta lactam
- colonization with mutidrug resistant the first week of hospitalization in intensive care unit
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description case number of Beta lactam class prescription for the same infection Patients are colonized patient by antimicrobial bacteria hospitalized in intensive care during the fist hospitalization in intensive care during 2016-2017. control number of Beta lactam class prescription for the same infection Patients aren't colonized patient by antimicrobial bacteria hospitalized in intensive care during the fist hospitalization in intensive care during 2016-2017.
- Primary Outcome Measures
Name Time Method number of Beta lactam class prescription 3 months
- Secondary Outcome Measures
Name Time Method